Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a2d48afac0355b28788bcbe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Relugolix 40 mg estradiol 1 mg norethisterone", "description": "Women suffering from heavy menstrual bleeding caused by uterine fibroids or pain associated with endometriosis often face challenges that affect their quality of life, daily activities, and overall well-being. Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is an advanced oral therapy specifically developed to address these conditions while maintaining hormonal balance and reducing treatment-related side effects.\n\nThis innovative combination treatment offers a non-surgical approach for managing symptoms such as excessive menstrual bleeding, pelvic pain, and discomfort caused by hormone-dependent gynecological disorders. If you are searching for an effective and clinically proven treatment option, understanding the benefits, mechanism of action, uses, and safety profile of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg can help you make an informed healthcare decision.\n\nWhat is Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nRelugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is a prescription medication used for the management of:\n\nHeavy menstrual bleeding associated with uterine fibroids\nModerate to severe pain associated with endometriosis\nHormone-dependent gynecological conditions requiring long-term symptom control\n\nThe combination contains three active ingredients that work together to reduce symptoms while minimizing the adverse effects commonly associated with hormone suppression therapies.\n\nComposition of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nRelugolix 40 mg\n\nRelugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It works by reducing the production of estrogen and progesterone from the ovaries, helping control the growth and symptoms of hormone-sensitive conditions.\n\nEstradiol 1 mg\n\nEstradiol is a form of estrogen included to maintain healthy estrogen levels and help prevent symptoms associated with estrogen deficiency.\n\nNorethisterone Acetate 0.5 mg\n\nNorethisterone acetate is a synthetic progestin that helps protect the uterine lining and contributes to hormonal balance during treatment.\n\nTogether, these ingredients create a balanced therapy that effectively manages symptoms while reducing the risk of bone density loss and menopausal-like side effects.\n\nHow Does Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg Work?\n\nThe medication utilizes a unique combination approach.\n\nSuppresses Excess Hormonal Activity\n\nRelugolix blocks GnRH receptors in the pituitary gland, reducing the release of hormones that stimulate ovarian estrogen production.\n\nReduces Fibroid-Related Bleeding\n\nLower estrogen levels help decrease fibroid activity, reducing heavy menstrual bleeding and improving quality of life.\n\nControls Endometriosis Symptoms\n\nBy suppressing estrogen production, Relugolix helps reduce the growth and activity of endometrial tissue outside the uterus, decreasing pain and inflammation.\n\nMaintains Hormonal Balance\n\nEstradiol and Norethisterone Acetate are added to provide “add-back therapy,” helping maintain hormonal balance and reducing the likelihood of menopausal symptoms.\n\nWhy is Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg Important?\n\nWomen with uterine fibroids and endometriosis often experience symptoms that interfere with daily life, including:\n\nExcessive menstrual bleeding\nSevere pelvic pain\nPainful periods\nFatigue caused by anemia\nPain during intercourse\nReduced productivity and quality of life\n\nThis combination treatment offers effective symptom management while helping patients avoid or delay surgical interventions in many cases.\n\nUses of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nHeavy Menstrual Bleeding Due to Uterine Fibroids\n\nThe medication significantly reduces menstrual blood loss associated with uterine fibroids.\n\nManagement of Endometriosis Pain\n\nIt helps control moderate to severe pain caused by endometriosis.\n\nLong-Term Symptom Control\n\nSuitable for patients requiring sustained symptom management under medical supervision.\n\nHormone-Dependent Gynecological Disorders\n\nMay be prescribed as part of a comprehensive treatment plan for selected hormone-sensitive conditions.\n\nKey Benefits of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nEffective Reduction of Heavy Menstrual Bleeding\n\nOne of the most significant benefits is the ability to substantially reduce excessive menstrual blood loss.\n\nImproved Pelvic Pain Management\n\nMany patients experience noticeable relief from endometriosis-related pelvic pain.\n\nNon-Surgical Treatment Option\n\nProvides an effective alternative to invasive procedures for suitable patients.\n\nMaintains Bone Health\n\nThe addition of Estradiol and Norethisterone Acetate helps reduce bone mineral density loss associated with hormone suppression.\n\nImproved Quality of Life\n\nPatients often report better physical comfort, improved energy levels, and enhanced daily functioning.\n\nConvenient Oral Administration\n\nThe once-daily oral tablet offers convenience and ease of use compared to injectable therapies.\n\nWho Can Benefit from Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nThis medication may be recommended for:\n\nWomen with symptomatic uterine fibroids\nPatients experiencing heavy menstrual bleeding\nWomen diagnosed with endometriosis\nIndividuals seeking non-surgical treatment options\nPatients requiring long-term symptom management\n\nA healthcare provider will determine whether this therapy is appropriate based on individual medical history and treatment goals.\n\nHow to Take Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\n\nFor optimal results:\n\nTake exactly as prescribed by your healthcare provider.\nUsually taken once daily.\nCan generally be taken with or without food.\nTake at the same time each day for consistent hormone control.\nDo not skip doses unless advised by your doctor.\n\nRegular follow-up appointments may be necessary to monitor treatment effectiveness and safety.\n\nPossible Side Effects\n\nLike all medications, side effects may occur.\n\nCommon Side Effects\nHot flashes\nHeadache\nFatigue\nMood changes\nIrregular bleeding\nNight sweats\nMild gastrointestinal discomfort\n\nMany side effects are mild and improve as treatment continues.\n\nLess Common Side Effects\nWeight changes\nBreast tenderness\nDizziness\nSleep disturbances\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSigns of blood clots\nSevere allergic reactions\nSignificant mood changes\nUnusual vaginal bleeding\nChest pain or shortness of breath\nImportant Safety Information\n\nBefore starting treatment, inform your healthcare provider if you have:\n\nHistory of blood clots\nCardiovascular disease\nLiver disease\nOsteoporosis\nHormone-sensitive cancers\nUnexplained vaginal bleeding\nSmoking history, especially over age 35\n\nA complete medical evaluation is essential before initiating therapy.\n\nDrug Interactions\n\nCertain medications may interact with Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg.\n\nExamples include:\n\nHormonal therapies\nAnticonvulsants\nCertain antibiotics\nAntifungal medications\nBlood thinners\nSome HIV medications\n\nAlways provide your doctor with a full list of medications and supplements you are taking.\n\nFrequently Asked Questions\nCan this medication cure uterine fibroids?\n\nNo. It helps manage symptoms and reduce bleeding but does not permanently eliminate fibroids.\n\nHow quickly does it start working?\n\nMany patients notice symptom improvement within the first few weeks of treatment, though individual responses vary.\n\nCan it help avoid surgery?\n\nIn some patients, symptom control may reduce the immediate need for surgical intervention. Your doctor will determine the best treatment approach.\n\nIs long-term use possible?\n\nTreatment duration depends on individual circumstances and medical supervision.\n\nCan it be used during pregnancy?\n\nNo. This medication should not be used during pregnancy. Effective contraception may be recommended during treatment.\n\nWhy Choose Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nThis advanced combination therapy offers a balanced approach to managing uterine fibroids and endometriosis. By combining hormone suppression with carefully selected hormone replacement components, it provides effective symptom relief while minimizing common treatment-related side effects.\n\nIts ability to reduce heavy menstrual bleeding, improve pelvic pain, support bone health, and offer a convenient oral dosing schedule makes it a preferred treatment option for many women seeking comprehensive symptom management.\n\nConclusion\n\nRelugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is a modern and effective therapy for women suffering from heavy menstrual bleeding associated with uterine fibroids and pain related to endometriosis. Through its unique combination of Relugolix, Estradiol, and Norethisterone Acetate, the medication helps control symptoms, improve quality of life, and provide a non-surgical treatment alternative.", "price": 845.0, "discountamount": 254.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2453, "imageuri": "https://productimages.withfloats.com/actual/6a2d48b1bb059c34f7b06bbe.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a2d48b1bb059c34f7b06bbe.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-13T12:10:23.243Z", "updatedon": "2026-06-13T12:10:23.243Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//relugolix-40-mg-estradiol-1-mg-norethisterone/2453", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RELUGOLINE 40/1/0.5", "category": "GYANECOLOGYRANGE", "tags": [ "relugolix 40 mg estradiol 1 mg norethisterone", "relugolix 40 mg estradiol 1 mg norethindrone acetate 0.5 mg tablet", "Buy Relugolix Estradiol Norethisterone Tablets Online", "Relugolix Combination Tablets for Uterine Fibroids", "Relugolix 40 mg Women's Health Medicine", "Relugolix 40 mg Estradiol 1 mg Norethisterone Product Image", "Best Relugolix Combination Tablets for Fibroid Management", "relugolix tablets for heavy menstrual bleeding in india", "Buy Relugolix 40 mg Estradiol 1 mg Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69df3ef834127e7b656ef646", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivaroxaban 2.5 mg", "description": "ROXARIVABEN 2.5 is a clinically trusted formulation of Rivaroxaban 2.5 mg, an advanced oral anticoagulant widely used for the prevention and management of thromboembolic disorders. It belongs to a class of medicines known as direct Factor Xa inhibitors, which work by preventing the formation of harmful blood clots in the body.\n\nBlood clot-related conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and cardiovascular complications can be life-threatening if not treated effectively. ROXARIVABEN 2.5 is specifically designed to reduce these risks by maintaining smooth blood flow and minimizing clot formation without the need for frequent monitoring like traditional anticoagulants.\n\nThis product is increasingly prescribed by healthcare professionals due to its predictable action, convenience, and proven efficacy in improving patient outcomes.\n\nHow Rivaroxaban 2.5 mg Works\n\nRivaroxaban works by selectively blocking Factor Xa, an essential enzyme in the blood coagulation process. Factor Xa plays a crucial role in converting prothrombin into thrombin, which ultimately leads to clot formation.\n\nBy inhibiting this step:\n\nIt reduces thrombin generation\nPrevents fibrin clot formation\nMaintains smooth blood circulation\n\nUnlike older anticoagulants, Rivaroxaban provides targeted action, minimizing complications while ensuring effective clot prevention.\n\nUses of ROXARIVABEN 2.5\n\nROXARIVABEN 2.5 is prescribed for multiple cardiovascular and thrombotic conditions. Some of its key uses include:\n\n1. Prevention of Cardiovascular Events\n\nIt is commonly used in patients with:\n\nCoronary artery disease (CAD)\nPeripheral artery disease (PAD)\n\nIt helps reduce the risk of:\n\nHeart attacks\nStroke\nCardiovascular death\n2. Deep Vein Thrombosis (DVT)\n\nPrevents and treats blood clots that form in deep veins, usually in the legs.\n\n3. Pulmonary Embolism (PE)\n\nUsed to prevent clots from traveling to the lungs, which can be life-threatening.\n\n4. Post-Surgical Clot Prevention\n\nRecommended after major surgeries (like knee or hip replacement) to prevent clot formation.\n\n5. Secondary Prevention\n\nHelps prevent recurrence of clotting events in high-risk patients.\n\nKey Benefits of ROXARIVABEN 2.5\n1. Effective Anticoagulation\n\nProvides reliable prevention against clot formation with a targeted mechanism of action.\n\n2. No Routine Monitoring Required\n\nUnlike warfarin, it does not require frequent INR monitoring, making it more convenient for patients.\n\n3. Predictable Pharmacokinetics\n\nOffers consistent and predictable results, reducing dose adjustments.\n\n4. Reduced Risk of Stroke & Heart Attack\n\nSignificantly lowers the chances of major cardiovascular events in high-risk individuals.\n\n5. Oral Administration\n\nEasy-to-take tablet form improves patient compliance compared to injectable anticoagulants.\n\n6. Rapid Onset of Action\n\nBegins working quickly after administration, providing faster protection.\n\n7. Lower Drug & Food Interactions\n\nHas fewer dietary restrictions compared to traditional anticoagulants.\n\nDosage and Administration\nThe typical dose is Rivaroxaban 2.5 mg, taken as prescribed by a healthcare professional.\nUsually taken twice daily with food for optimal absorption.\nDosage may vary depending on the condition and patient profile.\nImportant Guidelines:\nTake the medicine at the same time each day\nDo not skip doses\nDo not stop medication without consulting a doctor\nIf a dose is missed, take it as soon as remembered unless it’s close to the next dose\nSide Effects of ROXARIVABEN 2.5\n\nLike all medications, ROXARIVABEN 2.5 may cause some side effects. Most are mild, but some may require medical attention.\n\nCommon Side Effects:\nBleeding (minor bruising, nosebleeds)\nNausea\nHeadache\nDizziness\nModerate Side Effects:\nProlonged bleeding from cuts\nBlood in urine or stools\nFatigue or weakness\nSerious Side Effects (Seek Immediate Medical Help):\nSevere or uncontrolled bleeding\nVomiting blood or coughing blood\nSudden severe headache\nDifficulty breathing\nPrecautions and Warnings\n1. Bleeding Risk\n\nAs an anticoagulant, it increases the risk of bleeding. Patients should:\n\nAvoid activities with injury risk\nInform doctors before surgeries or dental procedures\n2. Kidney & Liver Conditions\n\nUse with caution in patients with:\n\nKidney impairment\nLiver disease\n3. Drug Interactions\n\nInform your doctor if you are taking:\n\nOther blood thinners\nNSAIDs\nCertain antibiotics or antifungals\n4. Pregnancy & Breastfeeding\nNot recommended unless prescribed\nConsult a doctor before use\n5. Elderly Patients\n\nMay require careful monitoring due to increased bleeding risk.\n\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nWhy Choose ROXARIVABEN 2.5?\n\nROXARIVABEN 2.5 stands out in the anticoagulant segment due to its:\n\nProven efficacy in cardiovascular protection\nEase of use and patient compliance\nMinimal monitoring requirements\nStrong safety and tolerability profile\n\nIt is an ideal choice for long-term management of thrombotic conditions and cardiovascular risk reduction.\n\nConclusion\nROXARIVABEN 2.5 (Rivaroxaban 2.5 mg) is a modern, reliable, and highly effective anticoagulant that plays a crucial role in preventing life-threatening clot-related complications. With its targeted mechanism, ease of administration, and reduced need for monitoring, it has become a preferred choice among healthcare professionals and patients alike.", "price": 117.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2379, "imageuri": "https://productimages.withfloats.com/actual/69df3f35d87dd0c2a3208b9c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69df3f35d87dd0c2a3208b9c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-15T07:32:08.559Z", "updatedon": "2026-04-15T08:04:06.502Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rivaroxaban-2-5-mg/2379", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROXARIVABEN 2.5", "category": "CARDIOLOGYRANGE", "tags": [ "rivaroxaban 2.5 mg", "rivaroxaban 2.5 mg uses in hindi", "rivaroxaban 2.5 mg uses", "rivaroxaban 2.5 mg tablet", "rivaroxaban 2.5 mg price", "tab rivaroxaban 2.5 mg uses", "rivaroxaban 2.5 mg tablet uses", "rivaroxaban 2.5 mg tablet", "rivaroxaban 2.5 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d8ed7add4a4181827e0297", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ceftriaxone tazobactam injection uses", "description": "Proceftazo 1125 is a powerful combination antibiotic injection containing Ceftriaxone and Tazobactam, formulated to treat a wide range of serious bacterial infections. This combination enhances antibacterial effectiveness by not only killing bacteria but also preventing resistance mechanisms that often reduce the impact of standard antibiotics.\n\nProceftazo 1125 is commonly administered in hospitals or clinical settings for moderate to severe infections requiring immediate and effective treatment.\n\nWhat is Proceftazo 1125 Injection?\n\nProceftazo 1125 is a dual-action antibiotic therapy that combines:\n\nCeftriaxone (1000 mg approx.) – a third-generation cephalosporin antibiotic that kills bacteria by disrupting their cell wall formation.\nTazobactam (125 mg approx.) – a beta-lactamase inhibitor that protects Ceftriaxone from bacterial enzymes that can inactivate it.\n\nTogether, they create a highly effective formulation that works against resistant and difficult-to-treat bacterial strains.\n\nUses of Proceftazo 1125 Injection\n\nProceftazo 1125 is widely prescribed for treating various bacterial infections, including:\n\n1. Respiratory Tract Infections\nPneumonia\nBronchitis\nLung abscess\n2. Urinary Tract Infections (UTIs)\nComplicated UTIs\nKidney infections\n3. Skin and Soft Tissue Infections\nCellulitis\nWound infections\nAbscesses\n4. Intra-Abdominal Infections\nPeritonitis\nGastrointestinal infections\n5. Bone and Joint Infections\nOsteomyelitis\nSeptic arthritis\n6. Bloodstream Infections\nSepsis and bacteremia\n7. Gynecological Infections\nPelvic inflammatory disease\n\nProceftazo 1125 is especially useful in treating infections caused by resistant bacteria, making it a reliable choice in critical care settings.\n\nHow Proceftazo 1125 Works\n\nThe combination of Ceftriaxone and Tazobactam provides a dual mechanism of action:\n\nCeftriaxone attacks and destroys bacterial cell walls, leading to bacterial death.\nTazobactam inhibits beta-lactamase enzymes produced by bacteria, which would otherwise neutralize Ceftriaxone.\n\nThis synergistic action ensures:\n\nBroader antibacterial coverage\nIncreased effectiveness against resistant strains\nFaster infection control\nKey Benefits of Proceftazo 1125 Injection\n1. Broad-Spectrum Antibiotic Coverage\n\nProceftazo 1125 is effective against a wide range of Gram-positive and Gram-negative bacteria.\n\n2. Enhanced Resistance Protection\n\nThanks to Tazobactam, this injection overcomes bacterial resistance mechanisms, making treatment more effective.\n\n3. Rapid Action\n\nBeing an injectable formulation, it works quickly, making it ideal for severe or life-threatening infections.\n\n4. Trusted in Hospital Settings\n\nFrequently used in intensive care units (ICUs) and emergency care for serious infections.\n\n5. Reduced Risk of Treatment Failure\n\nThe combination therapy lowers the chances of antibiotic resistance and relapse.\n\n6. Convenient Dosing\n\nUsually administered once or twice daily depending on the severity of infection.\n\nDosage and Administration\nProceftazo 1125 is administered via intramuscular (I.M.) or intravenous (I.V.) injection.\nDosage depends on:\nType and severity of infection\nPatient’s age and weight\nKidney and liver function\n\n⚠️ Always administered by a healthcare professional. Do not self-inject.\n\nPossible Side Effects of Proceftazo 1125\n\nWhile generally well-tolerated, some patients may experience side effects:\n\nCommon Side Effects\nPain or swelling at injection site\nDiarrhea\nNausea or vomiting\nRash\nModerate Side Effects\nAllergic reactions\nElevated liver enzymes\nHeadache or dizziness\nSerious Side Effects (Rare)\nSevere allergic reactions (anaphylaxis)\nBlood disorders\nClostridium difficile-associated diarrhea\nKidney or liver dysfunction\nWhen to Seek Medical Attention\n\nSeek immediate medical help if you experience:\n\nDifficulty breathing\nSevere rash or itching\nPersistent diarrhea\nYellowing of skin or eyes\nUnusual bleeding\nPrecautions and Warnings\nInform your doctor if you have allergies to cephalosporins or penicillin.\nUse cautiously in patients with kidney or liver disorders.\nNot recommended for premature infants or newborns without medical advice.\nAlcohol consumption should be avoided during treatment.\nDrug Interactions\n\nProceftazo 1125 may interact with:\n\nBlood thinners\nOther antibiotics\nDiuretics\nCalcium-containing IV solutions\n\nAlways inform your doctor about all medications you are taking.\n\nStorage Instructions\nStore below 25°C\nProtect from light and moisture\nKeep out of reach of children\nConclusion\n\nProceftazo 1125 Injection (Ceftriaxone & Tazobactam) is a highly effective, broad-spectrum antibiotic designed to combat serious and resistant bacterial infections. Its dual-action formula ensures enhanced bacterial killing and protection against resistance, making it a trusted choice in hospitals and critical care settings.\n\nWith its rapid action, wide applicability, and strong clinical effectiveness, Proceftazo 1125 plays a crucial role in modern infection management. However, it should always be used under strict medical supervision to ensure safety and effectiveness.", "price": 216.0, "discountamount": 64.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2376, "imageuri": "https://productimages.withfloats.com/actual/69d8ed7d8f2b0cae43c9890c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8ed7d8f2b0cae43c9890c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T12:30:50.916Z", "updatedon": "2026-04-14T12:47:51.463Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ceftriaxone-tazobactam-injection-uses/2376", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Proceftazo 1125", "category": "GENERAL RANGE", "tags": [ "ceftriaxone and tazobactam for injection", "ceftriaxone and tazobactam for injection 1125 mg", "ceftriaxone and tazobactam for injection uses", "ceftriaxone and tazobactam for injection in hindi", "ceftriaxone and tazobactam for injection 250 mg", "ceftriaxone and tazobactam for injection price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d8d68efa032a24fb0fc87e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "deferasirox dispersible tablets 500mg", "description": "Introduction to Defrosia 500\n\nDefrosia 500 is a clinically trusted iron chelation medicine containing Deferasirox 500 mg in dispersible tablet form. It is widely prescribed for patients suffering from chronic iron overload, a condition commonly caused by repeated blood transfusions in disorders such as thalassemia, sickle cell anemia, and other chronic anemias.\n\nExcess iron accumulation in the body can damage vital organs like the liver, heart, and endocrine glands. Defrosia 500 works effectively to remove this excess iron, helping patients maintain a healthier life and prevent long-term complications.\n\nWhat is Deferasirox and How Does It Work?\n\nDeferasirox is an oral iron chelator that binds to excess iron in the bloodstream. Once bound, the iron is removed from the body through stool, reducing iron levels safely over time.\n\nUnlike older treatments that required injections, Defrosia 500 dispersible tablets offer a convenient, once-daily oral solution, improving patient compliance and comfort.\n\nUses of Defrosia 500\n\nDefrosia 500 is primarily prescribed for:\n\n1. Chronic Iron Overload Due to Blood Transfusions\n\nPatients with conditions like the following:\n\nThalassemia major\nSickle cell disease\nMyelodysplastic syndromes\n\noften require frequent blood transfusions, leading to iron accumulation. Defrosia 500 helps remove this excess iron effectively.\n\n2. Non-Transfusion Dependent Iron Overload\n\nIt is also used in patients who accumulate iron naturally without regular transfusions.\n\n3. Prevention of Organ Damage\n\nBy controlling iron levels, Defrosia 500 helps prevent:\n\nLiver cirrhosis\nHeart complications\nHormonal imbalances\nKey Benefits of Defrosia 500\n1. Effective Iron Removal\n\nDefrosia 500 binds excess iron and eliminates it, reducing toxic buildup in the body.\n\n2. Once-Daily Oral Dosage\n\nUnlike injectable chelation therapies, Defrosia 500 is taken orally, making it more convenient and patient-friendly.\n\n3. Protects Vital Organs\n\nRegular use helps safeguard critical organs such as the following:\n\nLiver\nHeart\nPancreas\n4. Improves Quality of Life\n\nBy reducing iron overload symptoms like fatigue and weakness, patients experience improved overall well-being.\n\n5. Dispersible Form for Easy Consumption\n\nThe tablet dissolves in liquid, making it easier for patients who have difficulty swallowing pills.\n\nHow to Take Defrosia 500\nTake the medicine once daily on an empty stomach or as prescribed by your doctor.\nDissolve the tablet in water, orange juice, or apple juice before consumption.\nDo not chew or swallow the tablet whole.\nFollow your doctor’s dosage instructions carefully based on your body weight and iron levels.\nPossible Side Effects of Defrosia 500\n\nLike all medications, Defrosia 500 may cause side effects. Most are mild, but some may require medical attention.\n\nCommon Side Effects\nNausea or vomiting\nDiarrhea\nAbdominal pain\nSkin rash\nSerious Side Effects (Seek Medical Help)\nKidney problems (reduced urine, swelling)\nLiver issues (yellowing of skin or eyes)\nHearing or vision disturbances\nSevere allergic reactions\nMonitoring is important.\n\nDoctors usually recommend regular tests such as the following:\n\nSerum ferritin levels\nKidney function tests\nLiver function tests\n\nto ensure safe and effective treatment.\n\nPrecautions and Warnings\n\nBefore using Defrosia 500, consider the following:\n\nInform your doctor if you have kidney or liver disease\nNot recommended for patients with severe kidney impairment\nUse with caution in elderly patients\nAvoid during pregnancy unless prescribed\nNot suitable for children under medical supervision without guidance\nDrug Interactions\n\nDefrosia 500 may interact with certain medications such as:\n\nAntacids containing aluminum\nBlood thinners\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nWhy Choose Defrosia 500?\n\nDefrosia 500 stands out due to:\n\nProven effectiveness in iron chelation\nConvenient dispersible formulation\nReduced need for invasive treatments\nTrusted quality and safety profile\n\nIt is a preferred choice among healthcare professionals for managing iron overload conditions.\n\nConclusion\n\nDefrosia 500 (Deferasirox Dispersible Tablets 500 mg) is a highly effective and convenient treatment for managing chronic iron overload. With its once-daily oral dosing and strong safety profile, it helps patients maintain optimal iron levels and prevent serious complications affecting the liver, heart, and other organs.", "price": 395.0, "discountamount": 118.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2373, "imageuri": "https://productimages.withfloats.com/actual/69d8d6915352fce06529f3ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8d6915352fce06529f3ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T10:53:02.205Z", "updatedon": "2026-04-13T05:35:43.224Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//deferasirox-dispersible-tablets-500mg/2373", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Defrosia 500", "category": "GENERAL RANGE", "tags": [ "deferasirox dispersible tablets 500mg", "deferasirox dispersible tablet", "deferasirox dispersible tablets 500mg uses", "deferasirox dispersible tablets", "deferasirox dispersible tablets 500mg price", "deferasirox dispersible tablets 500mg uses in hindi", "deferasirox 500 mg price", "buy deferasirox dispersible tablets 500mg online", "buy deferasirox dispersible tablets 500mg for thalassemia", "deferasirox dispersible tablets wholesale price", "eferasirox 500 mg price per strip", "order Defrosia 500 deferasirox tablets online india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696ddf1a8f7ed3c5c7df9f01", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eltrombopag Olamine Tablets 50 mg", "description": "Eltrombopag Olamine Tablets 50 mg, marketed under the brand name LTROLAMINE 50, is a prescription medicine widely used in the management of low platelet count (thrombocytopenia) associated with certain blood disorders. It belongs to a class of medicines known as thrombopoietin receptor agonists, which work by stimulating platelet production in the bone marrow.\n\nLTROLAMINE 50 has become an important therapeutic option for patients who struggle with chronic platelet deficiency and are at increased risk of bleeding. With proven efficacy and a well-defined mechanism of action, this medication plays a crucial role in improving patient outcomes and quality of life.\n\nWhat is Eltrombopag Olamine Tablets 50 mg?\n\nEltrombopag Olamine Tablets 50 mg is an oral medication designed to increase platelet counts in patients whose body does not produce enough platelets naturally. Platelets are essential blood components responsible for clot formation and prevention of excessive bleeding.\n\nLTROLAMINE 50 is commonly prescribed for:\n\nChronic Immune Thrombocytopenia (ITP)\n\nSevere Aplastic Anemia\n\nThrombocytopenia associated with chronic Hepatitis C infection (in specific cases)\n\nBy improving platelet levels, LTROLAMINE 50 helps reduce bleeding risks and supports safer daily functioning for patients.\n\nUses of LTROLAMINE 50\n\nLTROLAMINE 50 is primarily used in the treatment of conditions characterized by low platelet counts, including:\n\n1. Chronic Immune Thrombocytopenia (ITP)\n\nIn patients with ITP, the immune system mistakenly destroys platelets. LTROLAMINE 50 stimulates platelet production, helping maintain a safer platelet count and lowering the risk of spontaneous bleeding.\n\n2. Severe Aplastic Anemia\n\nIn aplastic anemia, the bone marrow fails to produce sufficient blood cells. Eltrombopag Olamine supports bone marrow activity, leading to improved platelet and blood cell production when other treatments are ineffective.\n\n3. Hepatitis C–Associated Thrombocytopenia\n\nSome patients with chronic Hepatitis C experience low platelet counts that limit antiviral therapy. LTROLAMINE 50 may be used to raise platelet levels, enabling continuation of essential treatment under medical supervision.\n\nHow LTROLAMINE 50 Works\n\nEltrombopag Olamine acts as a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin (TPO) receptor found on bone marrow cells. This activation triggers a signaling process that stimulates the production of megakaryocytes—the cells responsible for forming platelets.\n\nUnlike platelet transfusions, which provide a temporary solution, LTROLAMINE 50 encourages the body to produce its own platelets, offering a more sustainable approach to managing thrombocytopenia.\n\nKey Benefits of LTROLAMINE 50\n\nLTROLAMINE 50 offers several clinically significant benefits:\n\n1. Increases Platelet Count Naturally\n\nBy stimulating bone marrow activity, LTROLAMINE 50 helps raise platelet levels without relying on transfusions.\n\n2. Reduces Bleeding Risk\n\nMaintaining adequate platelet counts significantly lowers the risk of bruising, nosebleeds, gum bleeding, and internal bleeding.\n\n3. Oral and Convenient Therapy\n\nAs an oral tablet, LTROLAMINE 50 is easy to administer and more comfortable for long-term use compared to injectable alternatives.\n\n4. Improves Quality of Life\n\nBy stabilizing platelet levels, patients can lead more active, confident lives with fewer hospital visits.\n\n5. Useful in Refractory Cases\n\nLTROLAMINE 50 is effective even in patients who do not respond adequately to first-line therapies like corticosteroids or immunoglobulins.\n\nDosage and Administration\n\nThe dosage of LTROLAMINE 50 is determined by the treating physician based on:\n\nPlatelet count\n\nUnderlying condition\n\nLiver function\n\nPatient response to therapy\n\nThe tablet is usually taken once daily, preferably on an empty stomach. Certain foods and supplements, especially those containing calcium, iron, magnesium, or aluminum, may interfere with absorption and should be avoided close to dosing time.\n\nPatients must strictly follow medical advice and undergo regular blood tests to monitor platelet levels and liver function.\n\nPossible Side Effects of LTROLAMINE 50\n\nLike all medicines, LTROLAMINE 50 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHeadache\n\nNausea or vomiting\n\nFatigue\n\nDiarrhea\n\nMuscle or joint pain\n\nThese effects are generally mild and tend to improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nElevated liver enzymes\n\nRisk of blood clots if platelet counts become too high\n\nLiver function abnormalities\n\nCataract development with long-term use (rare)\n\nPatients should immediately inform their healthcare provider if they notice symptoms such as yellowing of the skin or eyes, severe abdominal pain, chest pain, or sudden swelling in limbs.\n\nPrecautions and Warnings\n\nLTROLAMINE 50 should only be used under strict medical supervision.\n\nRegular blood tests are essential to avoid excessive platelet increase.\n\nCaution is advised in patients with liver disease.\n\nPregnant or breastfeeding women should consult their doctor before use.\n\nThe medicine should not be stopped abruptly without medical advice.\n\nConclusion\n\nEltrombopag Olamine Tablets 50 mg (LTROLAMINE 50) is a clinically proven and effective therapy for managing thrombocytopenia associated with serious blood disorders. By stimulating the body’s natural platelet production, LTROLAMINE 50 helps reduce bleeding risk, minimize hospital dependence, and improve overall patient well-being.", "price": 1640.0, "discountamount": 492.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2279, "imageuri": "https://productimages.withfloats.com/actual/696ddf1b2b30597eb3c9bc2a.png", "tileimageuri": "https://productimages.withfloats.com/tile/696ddf1b2b30597eb3c9bc2a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T07:36:58.313Z", "updatedon": "2026-03-14T06:47:29.988Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//eltrombopag-olamine-tablets-50-mg/2279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LTROLAMINE 50", "category": "GENERAL RANGE", "tags": [ "eltrombopag olamine tablets 50 mg", "eltrombopag 50 mg tablet uses", "eltrombopag olamine 50 mg tablets", "eltrombopag 50 mg dosage", "eltrombopag olamine tablet 50 mg price", "eltrombopag 50 mg tablet in India", "eltrombopag olamine tablets 50 mg for ITP", "eltrombopag 50 mg tablets for low platelet count", "eltrombopag olamine 50 mg tablets uses and benefits", "eltrombopag 50 mg tablet side effects", "how eltrombopag 50 mg works", "eltrombopag olamine tablets 50 mg mechanism of action", "eltrombopag 50 mg tablets for thrombocytopenia", "what is eltrombopag olamine 50 mg tablet", "eltrombopag 50 mg tablets indications", "eltrombopag olamine tablets 50 mg precautions", "eltrombopag 50 mg tablet dosage guidelines", "eltrombopag olamine tablets 50 mg safety profile", "buy eltrombopag olamine tablets 50 mg online", "eltrombopag 50 mg tablets wholesale supplier India", "eltrombopag olamine tablets 50 mg pharma company", "eltrombopag 50 mg tablets manufacturer in India", "eltrombopag olamine 50 mg tablets cost" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695b65af2800555f6696a6cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinacalcet 60 mg Tablet", "description": "CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets\nProduct Overview\nCINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body.\nThe 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet.\nUnderstanding How CINASELECT 60 Works\nCINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream.\nWhen you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH).\nBy lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders.\nPrimary Therapeutic Uses\nSecondary Hyperparathyroidism in Chronic Kidney Disease\nThe primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk.\nCINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues.\nHypercalcemia in Parathyroid Carcinoma\nCINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms.\nPrimary Hyperparathyroidism\nFor patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications.\nKey Benefits of CINASELECT 60\nEffective PTH Control\nClinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification.\nImproved Calcium-Phosphorus Balance\nBy reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life.\nReduced Cardiovascular Risk\nElevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients.\nBone Health Preservation\nUncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density.\nAlternative to Surgery\nFor patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky.\nQuality of Life Improvement\nBy controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity.\nConvenient Oral Administration\nCINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients.\nPotential Side Effects and Adverse Reactions\nCommon Side Effects\nPatients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication.\nDiarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue).\nSerious Side Effects Requiring Medical Attention\nHypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities.\nGastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk.\nAdynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels.\nCardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease.\nAllergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported.\nPrecautions and Contraindications\nCINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH.\nPregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment.\nDosage and Administration Guidelines\nCINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided.\nThe typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved.\nDose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response.\nMonitoring Requirements\nPatients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy.\nAdditionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation.\nStorage and Handling\nCINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package.\nConclusion\nCINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications.\nThe benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management.\nHowever, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2266, "imageuri": "https://productimages.withfloats.com/actual/695b65ebf30763183f64d4f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695b65ebf30763183f64d4f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T07:18:07.264Z", "updatedon": "2026-05-01T06:30:26.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinacalcet-60-mg-tablet/2266", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CINASELECT 60", "category": "NEPHROLOGYRANGE", "tags": [ "cinacalcet 60 mg", "cinacalcet mechanism of action.", "cinacalcet uses", "tab cinacalcet.", "cinacalcet dose.", "cinacalcet structure.", "cinacalcet tab.", "calcium and phosphorus levels in the bloodstream.", "parathyroid hormone secretion.", "calcium metabolism disorders.", "chronic kidney disease and parathyroid conditions.", "cinacalcet 60 mg", "cinacalcet 60", "Cinacalcet Tablets 60 mg price in India", "Buy Cinacalcet Tablets 60 mg online", "Cinacalcet 60 mg wholesale price", "Buy Cinacalcet Tablets 60 mg", "Get Cinacalcet Tablets 60 mg at best price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
injectable medication?

Still searching for
injectable medication?

Chat with us